Mid-Year Report

GENENTECH, INC for GENENTECH INC

Firm
Client
Income
—
Expenses
$941,000

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H.R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions

LobbyistCovered position, as disclosed
WALTER MOORE N/A
PETER JOSEPH MULLER CHIEF OF STAFF, REPRESENTATIVE ELLEN TAUSCHER
HEIDI L WAGNER N/A

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Food & Drug Administration (FDA)

Bills named: H.R. 3043 (110th), S. 1710 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, Entire Bill H.R. 1908, Patent Reform Act of 2007, Entire Bill

LobbyistCovered position, as disclosed
WALTER MOORE N/A
PETER JOSEPH MULLER CHIEF OF STAFF, REPRESENTATIVE ELLEN TAUSCHER
HEIDI L WAGNER N/A

Contacted: SENATE; Patent & Trademark Office (PTO); Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Medicare/Medicaid MMM

H. Con Res. 99, Budget Resolution; Medicare/Medicaid H. Con. Res. 21. Budget Resolution; Medicare/Medicaid H.R. 4, Medicare Prescription Drug Price Negotiation Act; Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act; Medicare "non-interference" provisions SCHIP, (Senate) Medicare cuts to finance Schip expansion H.R. 3162, CHAMP Act, Medicare Cuts to Finance SCHIP

LobbyistCovered position, as disclosed
WALTER MOORE N/A
PETER JOSEPH MULLER CHIEF OF STAFF, REPRESENTATIVE ELLEN TAUSCHER
HEIDI L WAGNER N/A

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 3 (110th), H.Con.Res. 99 (110th), H.R. 3162 (110th), H.R. 4 (110th), H.Con.Res. 21 (110th)

Budget/Appropriations BUD

H.R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation provisions S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation provisions H. Con. Res 99, Budget Resolution, Medicare/Medicaid, drug importaiton, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, mediare, healthcare provisions H.R. 3043, Labor-HHS-Education and Related Agnecies Appropriations Act, Medicare, healthcare provisions

LobbyistCovered position, as disclosed
WALTER MOORE N/A
PETER JOSEPH MULLER CHIEF OF STAFF, REPRESENTATIVE ELLEN TAUSCHER
HEIDI L WAGNER N/A

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Bills named: S.Con.Res. 21 (110th), S. 1710 (110th), H.R. 3161 (110th), H.Con.Res. 99 (110th), H.R. 3043 (110th), S. 1859 (110th)

Pharmacy PHA

S. 623, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biolgoics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovaction Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H.R. 2900, Food and Drug Administratio Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate); Medicare cuts to finance SCHIP expansion H.R. 3162; CHAMP Act; Medicare cuts to finance SCHIP expansion S. 1376; 340B Program Improvement and Integrity Act of 2007, 340 B Drug Price Expansion H.R. 2606, 340B Proram Improvement and Intergrity Act of 2007, 340 B Drug Price Expansion

LobbyistCovered position, as disclosed
WALTER MOORE N/A
PETER JOSEPH MULLER CHIEF OF STAFF, REPRESENTATIVE ELLEN TAUSCHER
HEIDI L WAGNER N/A

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Executive Office of the President (EOP)

Bills named: S. 1376 (110th), H.R. 1956 (110th), S. 1024 (110th), S. 467 (110th), S. 1082 (110th), S. 1695 (110th), H.R. 1038 (110th), S. 993 (110th), H.R. 2606 (110th), H.R. 2900 (110th), S. 596 (110th), H.R. 1561 (110th), S. 1505 (110th), H.Con.Res. 99 (110th), S. 623 (110th), S.Con.Res. 21 (110th), H.R. 3162 (110th), S. 484 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.